The Weekly Insight – August 7

07th Aug 2017

This Week in Review

Last Week from Texas Insight

  • HHSC: Drug Utilization Review Board: The Drug Utilization Review Board met in their quarterly meeting. They reviewed products for the preferred drug list (PDL), reviewed and adopted prior authorization criteria for certain drugs and reviewed selected drug classes on the PDL.

  • Aging Texas Well Advisory Committee: The Aging Texas Well Advisory Committee met in their quarterly meeting to receive information from partner organizations and program updates. In addition, they began the process of addressing the requirements under SB 1693.

  • Texas’ Overhaul of Child Welfare: Part V – SB 11: This report is the last in a series discussing the major child welfare legislation that Governor Greg Abbott signed after the close of the 85th regular session. In parts I-IV of this series, we provided a general overview of the circumstances necessitating the complete overhaul of child welfare in the state of Texas, and talked about the other major bills that were involved: House Bill 5, House Bill 4, and House Bill 7. In this last report discussing Senate Bill 11, we will include a summary of the major provisions of the bill, as well as its fiscal implications for the state.

Healthcare Policy News

  • President Trump pressed Republican lawmakers on Thursday to continue their push to overhaul the country’s healthcare system, diverging once again from his previous calls to let the Affordable Care Act “implode.” “Congress must do its job, keep its promise, live up to its word and repeal and replace ObamaCare,” Trump said to a crowd of supporters in Huntington, W.Va. “You have to do it.”
  • Ohio Gov. John Kasich (R) offered advice on how the GOP can better deal with healthcare on Sunday, saying Republicans need to be more ideologically flexible.“Republicans are going to have to admit that there’s going to be a group of people out there who are going to need help,” Kasich told CBS News’s John Dickerson on “Face the Nation.”

  • Notorious “Pharma Bro” Martin Shkreli was convicted on three counts of fraud, and now his sentencing hinges on investor impact and his social media antics.